More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

The following is a summary of “Global Delphi consensus on treatment goals for generalised pustular psoriasis,” published in the January 2025 issue of Dermatology by Barker et al. Generalized pustular ...

Vanda Pharmaceuticals and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise the ...

Secukinumab achieved complete symptom resolution in patients with pediatric generalized pustular psoriasis (GPP) by week 2, with sustained improvements through week 70. The treatment regimen was ...

Imsidolimab has successfully completed two global Phase 3 studies in Generalized Pustular Psoriasis Vanda expects to immediately begin preparing BLA and MAA applications for the US and EU Anaptys to ...

2003). Patients with hand and foot psoriasis should be viewed in a different light than patients with generalized psoriasis for a number of reasons. As the NPF (2007) points out, psoriasis in ...

Recent studies imply that acute generalized exanthematous pustulosis ... while Th-1-derived dermatoses, such as psoriasis and sarcoidosis, are ameliorated. AGEP, a neutrophile, cell-mediated ...

Vanda Pharmaceuticals (VNDA) and AnaptysBio (ANAB) announced an exclusive, global license agreement for the development and commercialization ...

"Vanda and AnaptysBio link for generalised pustular psoriasis therapy" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...